1. Celgene Corporation, Summit, NJ;
2. Medical Research Council Molecular Hematology Unit, Oxford Comprehensive Biomedical Research Centre, Weatherall Institute of Molecular Medicine, and Department of Hematology, Oxford University Hospital National Health Service Foundation Trust, University of Oxford, Oxford, United Kingdom;
3. Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY;
4. Gustave Roussy, Université Paris-Saclay, Villejuif, France;
5. Unité de Pathogénie Microbienne Moléculaire, Institut Pasteur, Paris, France;
6. Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY;
7. Hématologie Clinique, Gustave Roussy, Université Paris-Saclay, Villejuif, France;
8. Agios Pharmaceuticals, Inc., Cambridge, MA;
9. Center for Molecular Oncology and Department of Epidemiology and Biostatistics, and
10. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY